Horan Christopher bought ARTV
December 12, 2025 · Form 4 insider transaction
Horan Christopher bought 107,156 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
107,156
Price
$0.00
Total value
N/A
InsiderHoran Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 12, 2025
Shares owned after185,339
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan ("RSUs").; On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I.